KYNA, which is generally thought to contribute to immunosuppressive functions by regulating cytokine release from invariant natural killer T cells through G protein-coupled receptor 35 (GPR35) activation (29), has been reported to promote IL-6 secretion in experimental breast cancer cells by binding to AhR (30). The gene discussed is GPR35; the disease is breast carcinoma.